nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—SLC6A4—epilepsy syndrome	0.294	0.587	CbGaD
Dexmethylphenidate—CYP2D6—epilepsy syndrome	0.207	0.413	CbGaD
Dexmethylphenidate—SLC6A2—locus ceruleus—epilepsy syndrome	0.00923	0.147	CbGeAlD
Dexmethylphenidate—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.00542	0.0866	CbGeAlD
Dexmethylphenidate—SLC6A2—autonomic nervous system—epilepsy syndrome	0.0049	0.0783	CbGeAlD
Dexmethylphenidate—SLC6A3—ganglion—epilepsy syndrome	0.00338	0.0539	CbGeAlD
Dexmethylphenidate—SLC6A4—ganglion—epilepsy syndrome	0.00309	0.0494	CbGeAlD
Dexmethylphenidate—SLC6A2—ganglion—epilepsy syndrome	0.00272	0.0435	CbGeAlD
Dexmethylphenidate—SLC6A3—hindbrain—epilepsy syndrome	0.00256	0.0409	CbGeAlD
Dexmethylphenidate—SLC6A4—hindbrain—epilepsy syndrome	0.00235	0.0375	CbGeAlD
Dexmethylphenidate—SLC6A3—brainstem—epilepsy syndrome	0.00147	0.0234	CbGeAlD
Dexmethylphenidate—SLC6A3—forebrain—epilepsy syndrome	0.00142	0.0226	CbGeAlD
Dexmethylphenidate—SLC6A4—brainstem—epilepsy syndrome	0.00134	0.0215	CbGeAlD
Dexmethylphenidate—SLC6A3—telencephalon—epilepsy syndrome	0.0013	0.0208	CbGeAlD
Dexmethylphenidate—SLC6A4—forebrain—epilepsy syndrome	0.0013	0.0207	CbGeAlD
Dexmethylphenidate—SLC6A4—telencephalon—epilepsy syndrome	0.00119	0.0191	CbGeAlD
Dexmethylphenidate—SLC6A2—brainstem—epilepsy syndrome	0.00118	0.0189	CbGeAlD
Dexmethylphenidate—SLC6A2—forebrain—epilepsy syndrome	0.00114	0.0182	CbGeAlD
Dexmethylphenidate—CYP2D6—hindbrain—epilepsy syndrome	0.00113	0.0181	CbGeAlD
Dexmethylphenidate—SLC6A2—telencephalon—epilepsy syndrome	0.00105	0.0168	CbGeAlD
Dexmethylphenidate—SLC6A3—midbrain—epilepsy syndrome	0.000935	0.0149	CbGeAlD
Dexmethylphenidate—Hexylcaine—SCN3A—epilepsy syndrome	0.000913	0.117	CrCbGaD
Dexmethylphenidate—SLC6A3—spinal cord—epilepsy syndrome	0.000913	0.0146	CbGeAlD
Dexmethylphenidate—SLC6A4—midbrain—epilepsy syndrome	0.000857	0.0137	CbGeAlD
Dexmethylphenidate—SLC6A4—spinal cord—epilepsy syndrome	0.000836	0.0133	CbGeAlD
Dexmethylphenidate—SLC6A2—medulla oblongata—epilepsy syndrome	0.000826	0.0132	CbGeAlD
Dexmethylphenidate—SLC6A3—head—epilepsy syndrome	0.000811	0.0129	CbGeAlD
Dexmethylphenidate—SLC6A3—nervous system—epilepsy syndrome	0.000769	0.0123	CbGeAlD
Dexmethylphenidate—SLC6A4—head—epilepsy syndrome	0.000743	0.0119	CbGeAlD
Dexmethylphenidate—SLC6A3—central nervous system—epilepsy syndrome	0.00074	0.0118	CbGeAlD
Dexmethylphenidate—SLC6A3—cerebellum—epilepsy syndrome	0.000724	0.0115	CbGeAlD
Dexmethylphenidate—SLC6A4—nervous system—epilepsy syndrome	0.000705	0.0112	CbGeAlD
Dexmethylphenidate—SLC6A4—central nervous system—epilepsy syndrome	0.000678	0.0108	CbGeAlD
Dexmethylphenidate—SLC6A2—head—epilepsy syndrome	0.000654	0.0104	CbGeAlD
Dexmethylphenidate—CYP2D6—brainstem—epilepsy syndrome	0.000648	0.0103	CbGeAlD
Dexmethylphenidate—Hexylcaine—SCN1A—epilepsy syndrome	0.000641	0.0824	CrCbGaD
Dexmethylphenidate—CYP2D6—forebrain—epilepsy syndrome	0.000626	0.00999	CbGeAlD
Dexmethylphenidate—SLC6A2—nervous system—epilepsy syndrome	0.00062	0.0099	CbGeAlD
Dexmethylphenidate—SLC6A2—central nervous system—epilepsy syndrome	0.000597	0.00953	CbGeAlD
Dexmethylphenidate—SLC6A3—brain—epilepsy syndrome	0.000588	0.00938	CbGeAlD
Dexmethylphenidate—CYP2D6—telencephalon—epilepsy syndrome	0.000575	0.00918	CbGeAlD
Dexmethylphenidate—Hexylcaine—SCN2A—epilepsy syndrome	0.000565	0.0727	CrCbGaD
Dexmethylphenidate—SLC6A4—brain—epilepsy syndrome	0.000539	0.0086	CbGeAlD
Dexmethylphenidate—SLC6A2—brain—epilepsy syndrome	0.000474	0.00757	CbGeAlD
Dexmethylphenidate—Cyclopentolate—CHRM3—epilepsy syndrome	0.000454	0.0583	CrCbGaD
Dexmethylphenidate—Cyclopentolate—CHRM1—epilepsy syndrome	0.000423	0.0544	CrCbGaD
Dexmethylphenidate—Hyoscyamine—CHRM3—epilepsy syndrome	0.000404	0.052	CrCbGaD
Dexmethylphenidate—Homatropine Methylbromide—CHRM3—epilepsy syndrome	0.000382	0.0491	CrCbGaD
Dexmethylphenidate—Hyoscyamine—CHRM1—epilepsy syndrome	0.000377	0.0485	CrCbGaD
Dexmethylphenidate—CYP2D6—head—epilepsy syndrome	0.000358	0.00572	CbGeAlD
Dexmethylphenidate—Homatropine Methylbromide—CHRM1—epilepsy syndrome	0.000356	0.0458	CrCbGaD
Dexmethylphenidate—Atropine—CHRM3—epilepsy syndrome	0.000344	0.0442	CrCbGaD
Dexmethylphenidate—Ipratropium bromide—CHRM3—epilepsy syndrome	0.00034	0.0437	CrCbGaD
Dexmethylphenidate—CYP2D6—nervous system—epilepsy syndrome	0.00034	0.00542	CbGeAlD
Dexmethylphenidate—CYP2D6—central nervous system—epilepsy syndrome	0.000327	0.00522	CbGeAlD
Dexmethylphenidate—Atropine—CHRM1—epilepsy syndrome	0.000321	0.0412	CrCbGaD
Dexmethylphenidate—CYP2D6—cerebellum—epilepsy syndrome	0.00032	0.0051	CbGeAlD
Dexmethylphenidate—Ipratropium bromide—CHRM1—epilepsy syndrome	0.000317	0.0408	CrCbGaD
Dexmethylphenidate—Hyoscyamine—CHRM2—epilepsy syndrome	0.000308	0.0396	CrCbGaD
Dexmethylphenidate—Homatropine Methylbromide—CHRM2—epilepsy syndrome	0.000291	0.0374	CrCbGaD
Dexmethylphenidate—Cyclopentolate—BCHE—epilepsy syndrome	0.000288	0.037	CrCbGaD
Dexmethylphenidate—Atropine—CHRM2—epilepsy syndrome	0.000262	0.0337	CrCbGaD
Dexmethylphenidate—CYP2D6—brain—epilepsy syndrome	0.00026	0.00414	CbGeAlD
Dexmethylphenidate—Ipratropium bromide—CHRM2—epilepsy syndrome	0.000259	0.0333	CrCbGaD
Dexmethylphenidate—Methylphenidate—SLC6A4—epilepsy syndrome	0.000243	0.0313	CrCbGaD
Dexmethylphenidate—Methylphenidate—CYP2D6—epilepsy syndrome	0.000171	0.022	CrCbGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.000158	0.0019	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.000158	0.0019	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.000158	0.0019	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SYN1—epilepsy syndrome	0.000158	0.00189	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—NSF—epilepsy syndrome	0.000158	0.00189	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CLCN2—epilepsy syndrome	0.000157	0.00188	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—CLCN6—epilepsy syndrome	0.000157	0.00188	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NTRK2—epilepsy syndrome	0.000157	0.00188	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—SST—epilepsy syndrome	0.000157	0.00188	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GAD2—epilepsy syndrome	0.000156	0.00187	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1RN—epilepsy syndrome	0.000156	0.00187	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CHRNB2—epilepsy syndrome	0.000156	0.00187	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000154	0.00184	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—STXBP1—epilepsy syndrome	0.000154	0.00184	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000152	0.00182	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Monoamine Transport—TNF—epilepsy syndrome	0.000151	0.00181	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC1A1—epilepsy syndrome	0.00015	0.00179	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000146	0.00175	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC17A7—epilepsy syndrome	0.000145	0.00174	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000145	0.00173	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HBEGF—epilepsy syndrome	0.000145	0.00173	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TH—epilepsy syndrome	0.000144	0.00172	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GABRA5—epilepsy syndrome	0.000143	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CACNA1A—epilepsy syndrome	0.000143	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—ABAT—epilepsy syndrome	0.000143	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIA4—epilepsy syndrome	0.000143	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—KCNJ10—epilepsy syndrome	0.000143	0.00171	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—CRH—epilepsy syndrome	0.000142	0.0017	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Alpha-synuclein signaling—SRC—epilepsy syndrome	0.000142	0.00169	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC1A3—epilepsy syndrome	0.000141	0.00169	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIK2—epilepsy syndrome	0.000141	0.00169	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC35A2—epilepsy syndrome	0.00014	0.00168	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC35A3—epilepsy syndrome	0.00014	0.00168	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC12A5—epilepsy syndrome	0.00014	0.00168	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Parkinsons Disease Pathway—CASP3—epilepsy syndrome	0.000138	0.00165	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C19—epilepsy syndrome	0.000138	0.00165	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—ARHGEF9—epilepsy syndrome	0.000137	0.00164	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GABRA1—epilepsy syndrome	0.000137	0.00164	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC17A7—epilepsy syndrome	0.000137	0.00164	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GABRB3—epilepsy syndrome	0.000137	0.00164	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	0.000137	0.00164	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP2C19—epilepsy syndrome	0.000136	0.00163	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GAD1—epilepsy syndrome	0.000136	0.00162	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	0.000135	0.00162	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—epilepsy syndrome	0.000135	0.00161	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GLUL—epilepsy syndrome	0.000134	0.00161	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000134	0.0016	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000132	0.00158	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIA2—epilepsy syndrome	0.000132	0.00158	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Monoamine Transport—TNF—epilepsy syndrome	0.00013	0.00156	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC6A4—epilepsy syndrome	0.00013	0.00155	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000129	0.00155	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GABBR1—epilepsy syndrome	0.000129	0.00155	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC4A10—epilepsy syndrome	0.000128	0.00154	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC1A2—epilepsy syndrome	0.000127	0.00153	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIK1—epilepsy syndrome	0.000127	0.00153	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNA7—epilepsy syndrome	0.000127	0.00153	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000127	0.00152	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—NRF2 pathway—HMOX1—epilepsy syndrome	0.000127	0.00152	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—epilepsy syndrome	0.000126	0.00151	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—SLC6A1—epilepsy syndrome	0.000126	0.00151	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN2A—epilepsy syndrome	0.000126	0.00151	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIA1—epilepsy syndrome	0.000126	0.00151	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HBEGF—epilepsy syndrome	0.000124	0.00149	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GABRB2—epilepsy syndrome	0.000122	0.00146	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.00012	0.00144	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.00012	0.00144	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.00012	0.00144	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GAD2—epilepsy syndrome	0.00012	0.00143	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNB2—epilepsy syndrome	0.000119	0.00143	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—AVP—epilepsy syndrome	0.000119	0.00142	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC8A1—epilepsy syndrome	0.000119	0.00142	CbGpPWpGaD
Dexmethylphenidate—Ipratropium bromide—CYP2D6—epilepsy syndrome	0.000119	0.0152	CrCbGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—TH—epilepsy syndrome	0.000117	0.00141	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000117	0.0014	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—epilepsy syndrome	0.000117	0.0014	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—HTR7—epilepsy syndrome	0.000115	0.00138	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000115	0.00138	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Monoamine Transport—TNF—epilepsy syndrome	0.000115	0.00138	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—epilepsy syndrome	0.000115	0.00137	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000115	0.00137	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000115	0.00137	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—KCNMA1—epilepsy syndrome	0.000114	0.00136	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HES1—epilepsy syndrome	0.000113	0.00135	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—COX3—epilepsy syndrome	0.000112	0.00134	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.000112	0.00134	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.000111	0.00133	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HBEGF—epilepsy syndrome	0.00011	0.00132	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—NRF2 pathway—HMOX1—epilepsy syndrome	0.000109	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—MEF2C—epilepsy syndrome	0.000109	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNA4—epilepsy syndrome	0.000108	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—KCNJ11—epilepsy syndrome	0.000108	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIK2—epilepsy syndrome	0.000108	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC1A3—epilepsy syndrome	0.000108	0.0013	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC8A2—epilepsy syndrome	0.000106	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	0.000106	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	0.000106	0.00127	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—YWHAZ—epilepsy syndrome	0.000105	0.00126	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NGF—epilepsy syndrome	0.000104	0.00125	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GAD1—epilepsy syndrome	0.000104	0.00124	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—epilepsy syndrome	0.000104	0.00124	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	0.000102	0.00122	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	0.000101	0.00121	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	0.000101	0.00121	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GABBR1—epilepsy syndrome	9.91e-05	0.00119	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—epilepsy syndrome	9.9e-05	0.00119	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—AVP—epilepsy syndrome	9.72e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—SLC6A1—epilepsy syndrome	9.66e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIN2A—epilepsy syndrome	9.66e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIA1—epilepsy syndrome	9.66e-05	0.00116	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—NRF2 pathway—HMOX1—epilepsy syndrome	9.65e-05	0.00115	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—BCHE—epilepsy syndrome	9.56e-05	0.00114	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—SIRT1—epilepsy syndrome	9.53e-05	0.00114	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—APOD—epilepsy syndrome	9.34e-05	0.00112	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—DLG4—epilepsy syndrome	9.33e-05	0.00112	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNB2—epilepsy syndrome	9.15e-05	0.0011	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—GRIN2B—epilepsy syndrome	9.12e-05	0.00109	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	9.1e-05	0.00109	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	9.1e-05	0.00109	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PLCB1—epilepsy syndrome	9.02e-05	0.00108	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	8.68e-05	0.00104	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	8.34e-05	0.000999	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	8.32e-05	0.000996	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	8.32e-05	0.000996	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	8.32e-05	0.000996	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	8.32e-05	0.000996	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—CHRNA4—epilepsy syndrome	8.31e-05	0.000994	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—APOD—epilepsy syndrome	8.27e-05	0.00099	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	8.06e-05	0.000965	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	8.06e-05	0.000965	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	7.74e-05	0.000926	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	7.69e-05	0.000921	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	7.39e-05	0.000885	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	7.38e-05	0.000884	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	7.37e-05	0.000883	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	7.37e-05	0.000883	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	7.37e-05	0.000883	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	7.37e-05	0.000883	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—BCHE—epilepsy syndrome	7.32e-05	0.000876	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	7.27e-05	0.000871	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—DLG4—epilepsy syndrome	7.15e-05	0.000855	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	7.08e-05	0.000847	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—NOS2—epilepsy syndrome	7e-05	0.000838	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—GRIN2B—epilepsy syndrome	6.99e-05	0.000836	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Neuronal System—PLCB1—epilepsy syndrome	6.91e-05	0.000827	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	6.85e-05	0.00082	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.81e-05	0.000815	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	6.8e-05	0.000814	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	6.58e-05	0.000787	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	6.58e-05	0.000787	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	6.54e-05	0.000783	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	6.44e-05	0.000771	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	6.31e-05	0.000755	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	6.27e-05	0.00075	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	6.06e-05	0.000726	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	6.03e-05	0.000722	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	6.02e-05	0.000721	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP2C19—epilepsy syndrome	5.94e-05	0.000711	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—CYP11A1—epilepsy syndrome	5.9e-05	0.000707	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	5.87e-05	0.000703	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.86e-05	0.000702	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP2C19—epilepsy syndrome	5.86e-05	0.000701	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	5.86e-05	0.000701	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	5.83e-05	0.000698	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	5.83e-05	0.000698	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metapathway biotransformation—CYP11A1—epilepsy syndrome	5.82e-05	0.000697	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	5.69e-05	0.000681	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	5.59e-05	0.000669	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	5.42e-05	0.000649	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	5.36e-05	0.000642	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	5.23e-05	0.000626	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	5.19e-05	0.000622	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	4.97e-05	0.000595	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	4.91e-05	0.000588	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	4.75e-05	0.000569	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—Circadian rythm related genes—JUN—epilepsy syndrome	4.64e-05	0.000556	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	4.63e-05	0.000554	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	4.44e-05	0.000532	CbGpPWpGaD
Dexmethylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	4.26e-05	0.00051	CbGpPWpGaD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	4.24e-05	0.000507	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Zonisamide—epilepsy syndrome	4.17e-05	0.000121	CcSEcCtD
Dexmethylphenidate—Headache—Diazepam—epilepsy syndrome	4.17e-05	0.000121	CcSEcCtD
Dexmethylphenidate—Anxiety—Pregabalin—epilepsy syndrome	4.16e-05	0.000121	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Clonazepam—epilepsy syndrome	4.16e-05	0.000121	CcSEcCtD
Dexmethylphenidate—Anaemia—Gabapentin—epilepsy syndrome	4.16e-05	0.00012	CcSEcCtD
Dexmethylphenidate—SLC6A3—Neuronal System—PRKCB—epilepsy syndrome	4.15e-05	0.000497	CbGpPWpGaD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.15e-05	0.00012	CcSEcCtD
Dexmethylphenidate—Asthenia—Carbamazepine—epilepsy syndrome	4.14e-05	0.00012	CcSEcCtD
Dexmethylphenidate—Agitation—Gabapentin—epilepsy syndrome	4.13e-05	0.00012	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Phenytoin—epilepsy syndrome	4.13e-05	0.00012	CcSEcCtD
Dexmethylphenidate—Discomfort—Pregabalin—epilepsy syndrome	4.13e-05	0.00012	CcSEcCtD
Dexmethylphenidate—Nausea—Fosphenytoin—epilepsy syndrome	4.12e-05	0.000119	CcSEcCtD
Dexmethylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	4.12e-05	0.000493	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.11e-05	0.000119	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Topiramate—epilepsy syndrome	4.11e-05	0.000119	CcSEcCtD
Dexmethylphenidate—Angioedema—Gabapentin—epilepsy syndrome	4.11e-05	0.000119	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.11e-05	0.000119	CcSEcCtD
Dexmethylphenidate—Vomiting—Felbamate—epilepsy syndrome	4.1e-05	0.000119	CcSEcCtD
Dexmethylphenidate—Dry mouth—Pregabalin—epilepsy syndrome	4.09e-05	0.000118	CcSEcCtD
Dexmethylphenidate—Pruritus—Carbamazepine—epilepsy syndrome	4.08e-05	0.000118	CcSEcCtD
Dexmethylphenidate—Rash—Felbamate—epilepsy syndrome	4.07e-05	0.000118	CcSEcCtD
Dexmethylphenidate—Eye disorder—Topiramate—epilepsy syndrome	4.06e-05	0.000118	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—CA13—epilepsy syndrome	4.06e-05	0.000486	CbGpPWpGaD
Dexmethylphenidate—Dermatitis—Felbamate—epilepsy syndrome	4.06e-05	0.000118	CcSEcCtD
Dexmethylphenidate—Malaise—Gabapentin—epilepsy syndrome	4.06e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Vertigo—Gabapentin—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Headache—Felbamate—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Confusional state—Pregabalin—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Topiramate—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Flushing—Topiramate—epilepsy syndrome	4.04e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Syncope—Gabapentin—epilepsy syndrome	4.03e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Leukopenia—Gabapentin—epilepsy syndrome	4.03e-05	0.000117	CcSEcCtD
Dexmethylphenidate—Dizziness—Clonazepam—epilepsy syndrome	4.02e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Nausea—Vigabatrin—epilepsy syndrome	4.02e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Vomiting—Zonisamide—epilepsy syndrome	4.01e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Insomnia—Valproic Acid—epilepsy syndrome	4.01e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Oedema—Pregabalin—epilepsy syndrome	4e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Pregabalin—epilepsy syndrome	4e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Asthenia—Lamotrigine—epilepsy syndrome	4e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Dizziness—Phenytoin—epilepsy syndrome	4e-05	0.000116	CcSEcCtD
Dexmethylphenidate—Rash—Zonisamide—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Infection—Pregabalin—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Valproic Acid—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Palpitations—Gabapentin—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Dermatitis—Zonisamide—epilepsy syndrome	3.98e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Dizziness—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Nausea—Diazepam—epilepsy syndrome	3.96e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Gabapentin—epilepsy syndrome	3.95e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Headache—Zonisamide—epilepsy syndrome	3.95e-05	0.000115	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Valproic Acid—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Carbamazepine—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Angiopathy—Topiramate—epilepsy syndrome	3.95e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Pruritus—Lamotrigine—epilepsy syndrome	3.94e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Shock—Pregabalin—epilepsy syndrome	3.94e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Somnolence—Valproic Acid—epilepsy syndrome	3.94e-05	0.000114	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.94e-05	0.000471	CbGpPWpGaD
Dexmethylphenidate—Immune system disorder—Topiramate—epilepsy syndrome	3.93e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Pregabalin—epilepsy syndrome	3.93e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Cough—Gabapentin—epilepsy syndrome	3.93e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.92e-05	0.000114	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Topiramate—epilepsy syndrome	3.92e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Tachycardia—Pregabalin—epilepsy syndrome	3.91e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Chills—Topiramate—epilepsy syndrome	3.9e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Valproic Acid—epilepsy syndrome	3.9e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Convulsion—Gabapentin—epilepsy syndrome	3.9e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Skin disorder—Pregabalin—epilepsy syndrome	3.89e-05	0.000113	CcSEcCtD
Dexmethylphenidate—Hypertension—Gabapentin—epilepsy syndrome	3.88e-05	0.000112	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.87e-05	0.000112	CcSEcCtD
Dexmethylphenidate—Vomiting—Clonazepam—epilepsy syndrome	3.87e-05	0.000112	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Valproic Acid—epilepsy syndrome	3.85e-05	0.000112	CcSEcCtD
Dexmethylphenidate—Alopecia—Topiramate—epilepsy syndrome	3.84e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Vomiting—Phenytoin—epilepsy syndrome	3.84e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Rash—Clonazepam—epilepsy syndrome	3.84e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Dermatitis—Clonazepam—epilepsy syndrome	3.83e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Chest pain—Gabapentin—epilepsy syndrome	3.83e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Arthralgia—Gabapentin—epilepsy syndrome	3.83e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Myalgia—Gabapentin—epilepsy syndrome	3.83e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Nausea—Felbamate—epilepsy syndrome	3.83e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Vomiting—Oxcarbazepine—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Fatigue—Valproic Acid—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Anxiety—Gabapentin—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Anorexia—Pregabalin—epilepsy syndrome	3.82e-05	0.000111	CcSEcCtD
Dexmethylphenidate—Dizziness—Carbamazepine—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Lamotrigine—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Headache—Clonazepam—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Rash—Phenytoin—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Mental disorder—Topiramate—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Dermatitis—Phenytoin—epilepsy syndrome	3.81e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.8e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Rash—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Constipation—Valproic Acid—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Pain—Valproic Acid—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Headache—Phenytoin—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Erythema—Topiramate—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Malnutrition—Topiramate—epilepsy syndrome	3.79e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Discomfort—Gabapentin—epilepsy syndrome	3.78e-05	0.00011	CcSEcCtD
Dexmethylphenidate—Headache—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000109	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.76e-05	0.00045	CbGpPWpGaD
Dexmethylphenidate—Nausea—Zonisamide—epilepsy syndrome	3.75e-05	0.000109	CcSEcCtD
Dexmethylphenidate—Dry mouth—Gabapentin—epilepsy syndrome	3.75e-05	0.000108	CcSEcCtD
Dexmethylphenidate—Tension—Topiramate—epilepsy syndrome	3.71e-05	0.000108	CcSEcCtD
Dexmethylphenidate—Confusional state—Gabapentin—epilepsy syndrome	3.7e-05	0.000107	CcSEcCtD
Dexmethylphenidate—Dizziness—Lamotrigine—epilepsy syndrome	3.69e-05	0.000107	CcSEcCtD
Dexmethylphenidate—Nervousness—Topiramate—epilepsy syndrome	3.68e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Oedema—Gabapentin—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Vomiting—Carbamazepine—epilepsy syndrome	3.67e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Back pain—Topiramate—epilepsy syndrome	3.66e-05	0.000106	CcSEcCtD
Dexmethylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	3.65e-05	0.000437	CbGpPWpGaD
Dexmethylphenidate—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.65e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.65e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Infection—Gabapentin—epilepsy syndrome	3.65e-05	0.000106	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Topiramate—epilepsy syndrome	3.64e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Rash—Carbamazepine—epilepsy syndrome	3.64e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Dermatitis—Carbamazepine—epilepsy syndrome	3.63e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.62e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Insomnia—Pregabalin—epilepsy syndrome	3.62e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Nausea—Clonazepam—epilepsy syndrome	3.61e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Headache—Carbamazepine—epilepsy syndrome	3.61e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Shock—Gabapentin—epilepsy syndrome	3.61e-05	0.000105	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Gabapentin—epilepsy syndrome	3.6e-05	0.000104	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Pregabalin—epilepsy syndrome	3.6e-05	0.000104	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.6e-05	0.000104	CcSEcCtD
Dexmethylphenidate—Nausea—Phenytoin—epilepsy syndrome	3.59e-05	0.000104	CcSEcCtD
Dexmethylphenidate—Tachycardia—Gabapentin—epilepsy syndrome	3.58e-05	0.000104	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Pregabalin—epilepsy syndrome	3.57e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Nausea—Oxcarbazepine—epilepsy syndrome	3.57e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Vision blurred—Topiramate—epilepsy syndrome	3.57e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Skin disorder—Gabapentin—epilepsy syndrome	3.57e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Somnolence—Pregabalin—epilepsy syndrome	3.56e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.55e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Tremor—Topiramate—epilepsy syndrome	3.55e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Vomiting—Lamotrigine—epilepsy syndrome	3.54e-05	0.000103	CcSEcCtD
Dexmethylphenidate—Urticaria—Valproic Acid—epilepsy syndrome	3.52e-05	0.000102	CcSEcCtD
Dexmethylphenidate—Rash—Lamotrigine—epilepsy syndrome	3.51e-05	0.000102	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Topiramate—epilepsy syndrome	3.51e-05	0.000102	CcSEcCtD
Dexmethylphenidate—Dermatitis—Lamotrigine—epilepsy syndrome	3.51e-05	0.000102	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Valproic Acid—epilepsy syndrome	3.5e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Valproic Acid—epilepsy syndrome	3.5e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Anorexia—Gabapentin—epilepsy syndrome	3.5e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Anaemia—Topiramate—epilepsy syndrome	3.5e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Headache—Lamotrigine—epilepsy syndrome	3.49e-05	0.000101	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.49e-05	0.000417	CbGpPWpGaD
Dexmethylphenidate—Decreased appetite—Pregabalin—epilepsy syndrome	3.48e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Agitation—Topiramate—epilepsy syndrome	3.48e-05	0.000101	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.46e-05	0.0001	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.46e-05	0.000414	CbGpPWpGaD
Dexmethylphenidate—Fatigue—Pregabalin—epilepsy syndrome	3.45e-05	0.0001	CcSEcCtD
Dexmethylphenidate—Nausea—Carbamazepine—epilepsy syndrome	3.43e-05	9.92e-05	CcSEcCtD
Dexmethylphenidate—Pain—Pregabalin—epilepsy syndrome	3.42e-05	9.92e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Pregabalin—epilepsy syndrome	3.42e-05	9.92e-05	CcSEcCtD
Dexmethylphenidate—Malaise—Topiramate—epilepsy syndrome	3.41e-05	9.89e-05	CcSEcCtD
Dexmethylphenidate—Vertigo—Topiramate—epilepsy syndrome	3.4e-05	9.85e-05	CcSEcCtD
Dexmethylphenidate—Syncope—Topiramate—epilepsy syndrome	3.39e-05	9.83e-05	CcSEcCtD
Dexmethylphenidate—Leukopenia—Topiramate—epilepsy syndrome	3.39e-05	9.81e-05	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.35e-05	0.000401	CbGpPWpGaD
Dexmethylphenidate—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.35e-05	9.69e-05	CcSEcCtD
Dexmethylphenidate—Palpitations—Topiramate—epilepsy syndrome	3.35e-05	9.69e-05	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Topiramate—epilepsy syndrome	3.33e-05	9.63e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Gabapentin—epilepsy syndrome	3.32e-05	9.62e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Lamotrigine—epilepsy syndrome	3.31e-05	9.59e-05	CcSEcCtD
Dexmethylphenidate—Cough—Topiramate—epilepsy syndrome	3.3e-05	9.57e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Pregabalin—epilepsy syndrome	3.3e-05	9.56e-05	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Gabapentin—epilepsy syndrome	3.3e-05	9.55e-05	CcSEcCtD
Dexmethylphenidate—Convulsion—Topiramate—epilepsy syndrome	3.28e-05	9.5e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.27e-05	9.48e-05	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Gabapentin—epilepsy syndrome	3.27e-05	9.48e-05	CcSEcCtD
Dexmethylphenidate—Hypertension—Topiramate—epilepsy syndrome	3.27e-05	9.46e-05	CcSEcCtD
Dexmethylphenidate—Somnolence—Gabapentin—epilepsy syndrome	3.26e-05	9.45e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.26e-05	9.45e-05	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Gabapentin—epilepsy syndrome	3.23e-05	9.36e-05	CcSEcCtD
Dexmethylphenidate—Myalgia—Topiramate—epilepsy syndrome	3.22e-05	9.33e-05	CcSEcCtD
Dexmethylphenidate—Chest pain—Topiramate—epilepsy syndrome	3.22e-05	9.33e-05	CcSEcCtD
Dexmethylphenidate—Arthralgia—Topiramate—epilepsy syndrome	3.22e-05	9.33e-05	CcSEcCtD
Dexmethylphenidate—Anxiety—Topiramate—epilepsy syndrome	3.21e-05	9.3e-05	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.2e-05	9.27e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Gabapentin—epilepsy syndrome	3.19e-05	9.24e-05	CcSEcCtD
Dexmethylphenidate—Discomfort—Topiramate—epilepsy syndrome	3.18e-05	9.22e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Pregabalin—epilepsy syndrome	3.18e-05	9.21e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Valproic Acid—epilepsy syndrome	3.18e-05	9.2e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.17e-05	9.18e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Gabapentin—epilepsy syndrome	3.17e-05	9.17e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Pregabalin—epilepsy syndrome	3.17e-05	9.17e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Pregabalin—epilepsy syndrome	3.17e-05	9.17e-05	CcSEcCtD
Dexmethylphenidate—Dry mouth—Topiramate—epilepsy syndrome	3.15e-05	9.13e-05	CcSEcCtD
Dexmethylphenidate—Pain—Gabapentin—epilepsy syndrome	3.14e-05	9.09e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Gabapentin—epilepsy syndrome	3.14e-05	9.09e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Valproic Acid—epilepsy syndrome	3.13e-05	9.08e-05	CcSEcCtD
Dexmethylphenidate—Confusional state—Topiramate—epilepsy syndrome	3.12e-05	9.02e-05	CcSEcCtD
Dexmethylphenidate—Oedema—Topiramate—epilepsy syndrome	3.09e-05	8.95e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.09e-05	0.00037	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PDXK—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—FAR1—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ADK—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GLUD1—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—L2HGDH—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CERS1—epilepsy syndrome	3.08e-05	0.000369	CbGpPWpGaD
Dexmethylphenidate—Infection—Topiramate—epilepsy syndrome	3.07e-05	8.89e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.06e-05	0.000366	CbGpPWpGaD
Dexmethylphenidate—Shock—Topiramate—epilepsy syndrome	3.04e-05	8.8e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Valproic Acid—epilepsy syndrome	3.03e-05	8.78e-05	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Topiramate—epilepsy syndrome	3.03e-05	8.77e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Gabapentin—epilepsy syndrome	3.03e-05	8.76e-05	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Topiramate—epilepsy syndrome	3.02e-05	8.76e-05	CcSEcCtD
Dexmethylphenidate—Tachycardia—Topiramate—epilepsy syndrome	3.02e-05	8.73e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3e-05	8.7e-05	CcSEcCtD
Dexmethylphenidate—Skin disorder—Topiramate—epilepsy syndrome	3e-05	8.69e-05	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Topiramate—epilepsy syndrome	2.99e-05	8.65e-05	CcSEcCtD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.97e-05	0.000355	CbGpPWpGaD
Dexmethylphenidate—Hypersensitivity—Pregabalin—epilepsy syndrome	2.95e-05	8.54e-05	CcSEcCtD
Dexmethylphenidate—Anorexia—Topiramate—epilepsy syndrome	2.94e-05	8.53e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Valproic Acid—epilepsy syndrome	2.93e-05	8.48e-05	CcSEcCtD
Dexmethylphenidate—Urticaria—Gabapentin—epilepsy syndrome	2.92e-05	8.45e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Gabapentin—epilepsy syndrome	2.9e-05	8.41e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Gabapentin—epilepsy syndrome	2.9e-05	8.41e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Pregabalin—epilepsy syndrome	2.87e-05	8.32e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Pregabalin—epilepsy syndrome	2.83e-05	8.2e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—GAMT—epilepsy syndrome	2.82e-05	0.000337	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—EPM2A—epilepsy syndrome	2.82e-05	0.000337	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PNPO—epilepsy syndrome	2.82e-05	0.000337	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NHLRC1—epilepsy syndrome	2.82e-05	0.000337	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Valproic Acid—epilepsy syndrome	2.82e-05	8.16e-05	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.81e-05	8.15e-05	CcSEcCtD
Dexmethylphenidate—Insomnia—Topiramate—epilepsy syndrome	2.79e-05	8.09e-05	CcSEcCtD
Dexmethylphenidate—Rash—Valproic Acid—epilepsy syndrome	2.79e-05	8.09e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Valproic Acid—epilepsy syndrome	2.79e-05	8.08e-05	CcSEcCtD
Dexmethylphenidate—Headache—Valproic Acid—epilepsy syndrome	2.77e-05	8.04e-05	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Topiramate—epilepsy syndrome	2.77e-05	8.03e-05	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Topiramate—epilepsy syndrome	2.75e-05	7.98e-05	CcSEcCtD
Dexmethylphenidate—Somnolence—Topiramate—epilepsy syndrome	2.75e-05	7.95e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Pregabalin—epilepsy syndrome	2.74e-05	7.93e-05	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Topiramate—epilepsy syndrome	2.72e-05	7.88e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Gabapentin—epilepsy syndrome	2.71e-05	7.83e-05	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Topiramate—epilepsy syndrome	2.69e-05	7.78e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.67e-05	7.72e-05	CcSEcCtD
Dexmethylphenidate—Fatigue—Topiramate—epilepsy syndrome	2.66e-05	7.71e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Pregabalin—epilepsy syndrome	2.65e-05	7.67e-05	CcSEcCtD
Dexmethylphenidate—Constipation—Topiramate—epilepsy syndrome	2.64e-05	7.65e-05	CcSEcCtD
Dexmethylphenidate—Pain—Topiramate—epilepsy syndrome	2.64e-05	7.65e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Gabapentin—epilepsy syndrome	2.63e-05	7.63e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Valproic Acid—epilepsy syndrome	2.63e-05	7.62e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—QDPR—epilepsy syndrome	2.62e-05	0.000313	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CA4—epilepsy syndrome	2.62e-05	0.000313	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Biological oxidations—POMC—epilepsy syndrome	2.61e-05	0.000312	CbGpPWpGaD
Dexmethylphenidate—Pruritus—Gabapentin—epilepsy syndrome	2.6e-05	7.52e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Pregabalin—epilepsy syndrome	2.55e-05	7.37e-05	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Topiramate—epilepsy syndrome	2.55e-05	7.37e-05	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.53e-05	7.32e-05	CcSEcCtD
Dexmethylphenidate—Rash—Pregabalin—epilepsy syndrome	2.52e-05	7.31e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Pregabalin—epilepsy syndrome	2.52e-05	7.31e-05	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Gabapentin—epilepsy syndrome	2.51e-05	7.28e-05	CcSEcCtD
Dexmethylphenidate—Headache—Pregabalin—epilepsy syndrome	2.51e-05	7.26e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—COX3—epilepsy syndrome	2.46e-05	0.000295	CbGpPWpGaD
Dexmethylphenidate—Urticaria—Topiramate—epilepsy syndrome	2.45e-05	7.11e-05	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Topiramate—epilepsy syndrome	2.44e-05	7.07e-05	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Topiramate—epilepsy syndrome	2.44e-05	7.07e-05	CcSEcCtD
Dexmethylphenidate—Dizziness—Gabapentin—epilepsy syndrome	2.43e-05	7.03e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Pregabalin—epilepsy syndrome	2.38e-05	6.89e-05	CcSEcCtD
Dexmethylphenidate—Vomiting—Gabapentin—epilepsy syndrome	2.33e-05	6.76e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—KCNB1—epilepsy syndrome	2.33e-05	0.000279	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLCO1A2—epilepsy syndrome	2.33e-05	0.000279	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PFKL—epilepsy syndrome	2.33e-05	0.000279	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC6A8—epilepsy syndrome	2.33e-05	0.000279	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CACNA2D2—epilepsy syndrome	2.33e-05	0.000279	CbGpPWpGaD
Dexmethylphenidate—Rash—Gabapentin—epilepsy syndrome	2.32e-05	6.7e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Gabapentin—epilepsy syndrome	2.31e-05	6.7e-05	CcSEcCtD
Dexmethylphenidate—Headache—Gabapentin—epilepsy syndrome	2.3e-05	6.66e-05	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Topiramate—epilepsy syndrome	2.28e-05	6.59e-05	CcSEcCtD
Dexmethylphenidate—Asthenia—Topiramate—epilepsy syndrome	2.22e-05	6.42e-05	CcSEcCtD
Dexmethylphenidate—Pruritus—Topiramate—epilepsy syndrome	2.19e-05	6.33e-05	CcSEcCtD
Dexmethylphenidate—Nausea—Gabapentin—epilepsy syndrome	2.18e-05	6.32e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—NEU1—epilepsy syndrome	2.13e-05	0.000255	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—UPB1—epilepsy syndrome	2.13e-05	0.000255	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ATIC—epilepsy syndrome	2.13e-05	0.000255	CbGpPWpGaD
Dexmethylphenidate—Diarrhoea—Topiramate—epilepsy syndrome	2.11e-05	6.12e-05	CcSEcCtD
Dexmethylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.09e-05	0.000251	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HSD17B4—epilepsy syndrome	2.05e-05	0.000246	CbGpPWpGaD
Dexmethylphenidate—Dizziness—Topiramate—epilepsy syndrome	2.04e-05	5.92e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—GBE1—epilepsy syndrome	1.98e-05	0.000238	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PPP1R3C—epilepsy syndrome	1.98e-05	0.000238	CbGpPWpGaD
Dexmethylphenidate—Vomiting—Topiramate—epilepsy syndrome	1.96e-05	5.69e-05	CcSEcCtD
Dexmethylphenidate—Rash—Topiramate—epilepsy syndrome	1.95e-05	5.64e-05	CcSEcCtD
Dexmethylphenidate—Dermatitis—Topiramate—epilepsy syndrome	1.95e-05	5.64e-05	CcSEcCtD
Dexmethylphenidate—Headache—Topiramate—epilepsy syndrome	1.94e-05	5.6e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—ASAH1—epilepsy syndrome	1.87e-05	0.000223	CbGpPWpGaD
Dexmethylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.85e-05	0.000222	CbGpPWpGaD
Dexmethylphenidate—Nausea—Topiramate—epilepsy syndrome	1.84e-05	5.31e-05	CcSEcCtD
Dexmethylphenidate—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.81e-05	0.000217	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALAD—epilepsy syndrome	1.77e-05	0.000212	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—NT5E—epilepsy syndrome	1.77e-05	0.000212	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	1.69e-05	0.000202	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	1.69e-05	0.000202	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	1.65e-05	0.000198	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ADSL—epilepsy syndrome	1.62e-05	0.000194	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GLUL—epilepsy syndrome	1.59e-05	0.00019	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	1.56e-05	0.000186	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	1.46e-05	0.000174	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AQP1—epilepsy syndrome	1.41e-05	0.000169	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	1.28e-05	0.000153	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	1.28e-05	0.000153	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.04e-05	0.000125	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.02e-05	0.000122	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.01e-05	0.000121	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	8.67e-06	0.000104	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—BCHE—epilepsy syndrome	8.64e-06	0.000103	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	8.24e-06	9.86e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	8.15e-06	9.76e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—TH—epilepsy syndrome	8.12e-06	9.72e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	6.78e-06	8.11e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—CAT—epilepsy syndrome	6.69e-06	8e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	6.51e-06	7.79e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.05e-06	7.24e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AGT—epilepsy syndrome	5.3e-06	6.35e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.2e-06	6.22e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—POMC—epilepsy syndrome	4.46e-06	5.34e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.07e-06	4.87e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	3.56e-06	4.26e-05	CbGpPWpGaD
Dexmethylphenidate—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.79e-06	2.14e-05	CbGpPWpGaD
